GlassScriptPhysician profile
Henry Dollahite
NPI 1104243468
$621.07
in general payments reported to CMS, 2019-2025
7 companies · $68.45 in 2025
The $68.45 reported for 2025 was less than what a typical Adult Medicine provider received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $42.43 · 2022: $134 · 2023: $215 · 2024: $38.06 · 2025: $68.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $321.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $339.55 | 2022-2024 | Endurant Iis |
| Janssen Pharmaceuticals, INC | $83.01 | 2019-2023 | Xarelto |
| Smith+Nephew, INC. | $68.45 | 2025 | Collagenase Santyl |
| Portola Pharmaceuticals, LLC | $49.99 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.77 | 2019 | |
| Kerecis Limited | $30.96 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Pfizer INC. | $15.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Dollahite listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.